INSACOG Alerts: What NB.1.8.1 and LF.7 Variants Mean

  • Share this:
post-title

The COVID-19 virus continues to evolve, and with each new variant, health experts and government bodies work quickly to monitor and manage potential risks. Recently, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) issued an alert about two new variants: NB.1.8.1 and LF.7.

But what do these names mean? And should you be worried? In this blog, we’ll explain what these variants are, how they might affect you, and how you can stay protected.

What is INSACOG and Why Their Alerts Matter

INSACOG is a group of national laboratories set up by the Government of India to monitor the genetic changes in the COVID-19 virus. By keeping track of how the virus changes over time, they help health authorities prepare for possible outbreaks and guide treatment strategies.

When INSACOG issues an alert, it means they have noticed something important—either a rise in cases due to a new variant or a mutation that could impact how the virus spreads or responds to treatments.

Need an Appointment?

What Are the NB.1.8.1 and LF.7 Variants?

Both NB.1.8.1 and LF.7 are sub-lineages of the Omicron variant, which has been dominant in many parts of the world for the last few years. These newer sub-variants show slight genetic differences from earlier versions, which may affect their behavior.

1. NB.1.8.1 Variant

  • This variant has been detected in several regions.
  • It shows mutations that may help it spread faster from person to person.
  • There is no strong evidence yet that it causes more severe illness.

2. LF.7 Variant

  • Similar to other Omicron-related strains, it appears to be highly transmissible.
  • It may evade some immunity, especially in people who haven't had recent booster shots.
  • Symptoms are generally mild to moderate, but it can still pose a risk to older adults or those with underlying conditions.

Are These Variants More Dangerous?

Current data suggests that NB.1.8.1 and LF.7 do not cause more severe disease than previous Omicron variants. Most people infected with these strains experience mild symptoms like:

  • Fever
  • Cough
  • Fatigue
  • Sore throat

However, those with weak immune systems, elderly individuals, and people with chronic health conditions may still face higher risks of complications.

How Do These Variants Spread?

Both NB.1.8.1 and LF.7 spread through respiratory droplets, just like earlier COVID-19 strains. They can pass from one person to another through:

  • Coughing and sneezing
  • Talking closely with someone infected
  • Touching contaminated surfaces and then touching your face

What makes these variants more challenging is that they may spread even faster than previous versions, making it easier for them to infect groups of people quickly.

How Can You Protect Yourself and Others?

While new variants may sound alarming, there are still simple, effective ways to protect yourself and your loved ones:

1. Get Vaccinated and Boosted
Vaccines continue to offer strong protection against severe illness, hospitalization, and death—even against newer variants. If you’re eligible, get your booster shot.

2. Wear a Mask in Crowded Places
In enclosed or crowded settings, especially during outbreaks, wearing a mask can reduce the risk of infection.

3. Practice Good Hygiene
Regular handwashing and avoiding touching your face can limit the spread of germs.

4. Stay Home If You're Sick
Even if your symptoms are mild, staying home helps protect those who are more vulnerable.

5. Monitor Updates from Trusted Sources
Keep an eye on official updates from health departments and hospitals like Continental Hospitals to stay informed.

Should You Get Tested for These Variants?

If you have symptoms or have been exposed to someone with COVID-19, getting tested is important. While standard RT-PCR tests detect COVID-19, variant-specific testing is usually done at labs under programs like INSACOG to track trends, not for individual diagnosis.

You don’t need special testing for these variants unless advised by your doctor.

  • What to Do If You Test Positive
  • If you test positive, follow these steps:
  • Isolate at home and monitor your symptoms.
  • Contact your doctor for advice on managing your condition.
  • Rest, stay hydrated, and follow any prescribed treatments.
  • Seek immediate help if you develop breathing trouble, chest pain, or high fever.

Continental Hospitals offers both virtual consultations and in-person care for COVID-19 and respiratory illnesses. Early care makes a big difference.

Why Choose Continental Hospitals?

At Continental Hospitals, your health and safety are our top priorities. Here's why thousands trust us during uncertain times:

Expert Team: Our infectious disease specialists, pulmonologists, and emergency care teams are experienced in managing COVID-19 and its variants.

Advanced Diagnostics: We use updated testing methods and track global alerts from WHO and INSACOG.

Safe Environment: Our hospital follows strict infection control practices to ensure patient safety.

Comprehensive Care: From early diagnosis to post-COVID recovery, we offer full support every step of the way.

We believe in giving you the care and information you need, right when you need it.

Conclusion: Stay Informed, Stay Protected

The appearance of NB.1.8.1 and LF.7 is a reminder that COVID-19 is still evolving. But you don’t have to panic. By staying informed and following safety steps, you can continue to live your life while reducing your risk.

INSACOG alerts help our healthcare system stay a step ahead—and Continental Hospitals is here to guide you through it all.

Feeling unwell or exposed to COVID? Don’t wait—consult the our best infectious disease specialist in Hyderabad at Continental Hospitals. We’re here to help you recover safely and quickly.

Frequently Asked Questions

NB.1.8.1 and LF.7 are new subvariants of the Omicron lineage identified by INSACOG, with potential for increased transmissibility or immune escape.
INSACOG (Indian SARS-CoV-2 Genomics Consortium) is a network of laboratories in India that tracks and studies emerging COVID-19 variants.
These variants have been detected in parts of India and are under close monitoring due to their mutation patterns.
Early data suggests these variants may be more transmissible, but further studies are needed to confirm.
Vaccines still offer protection against severe disease, though breakthrough infections may occur due to mutations.
Health authorities are monitoring them closely. Following public health guidelines is still the best protection.
NB.1.8.1 and LF.7 may have unique mutations in the spike protein that could affect transmission and immune response.
Yes, genome sequencing is essential to detect and classify new variants like NB.1.8.1 and LF.7.
Disclaimer: The information provided in this blog is intended for general knowledge and informational purposes only, and does not constitute medical advice. Always consult with a qualified healthcare professional for any medical concerns or before making any decisions about your health.